News
Videos
Conferences
Events
Resources
Subscribe

|Videos|March 7, 2021

Educated Patient® Breast Cancer Summit: March 7, 2021

Author(s)CURE staff

View the full CURE Educated Patient Breast Cancer Summit on demand.

Newsletter

Stay up to date on cancer updates, research and education

Related Content

image of Fda.

FDA Approves First Interchangeable Biosimilar to Perjeta in HER2+ Breast Cancer

November 13th 2025

Bonnie Annis

When One Blood Draw Could Tell More: A Look at the Cancerguard Test

November 13th 2025

After her own breast cancer treatment, Maureen advocated for legislation to make scalp cooling more accessible for patients seeking to preserve their hair.

Breast Cancer Survivor Advocates for Access to Scalp Cooling

ByMaureen Green

November 12th 2025

For Maureen Green, scalp cooling was a crucial part of her breast cancer treatment journey, as it prevented chemotherapy-induced hair loss.

Scalp Cooling Can Prevent Hair Loss During Chemo for Breast Cancer

November 12th 2025

Image of woman.

Dealing With Peripheral Neuropathy After Breast Cancer Treatment

ByCynthia Malaran

November 12th 2025

Trending on CURE

FDA Approves Komzifti for NPM1-Mutant Acute Myeloid Leukemia

FDA Approves First Interchangeable Biosimilar to Perjeta in HER2+ Breast Cancer

Cancer Experts Share Emerging Treatments Patients Should Know in 2026

Experts Highlight Notable Advances in Colorectal Cancer at 2025 ESMO

FDA Grants Drug Designation to Tinostamustine for Malignant Glioma

© 2025 MJH Life Sciences^®

All rights reserved.